サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1401004

スプリセル市場：デモグラフィック別、サイコグラフィック別、行動別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年

Sprycel Market, By Demographic, By Psychographic, By Behavioral, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日
ページ情報
英文 296 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
スプリセル市場：デモグラフィック別、サイコグラフィック別、行動別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年
出版日: 2023年12月17日
発行: AnalystView Market Insights
ページ情報: 英文 296 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

スプリセルの市場規模は2022年に54億7,000万米ドルとなり、2023年から2030年にかけてCAGR 5.2%で拡大すると予想されます。

スプリセル市場- 市場力学

チロシンキナーゼとして知られる特定のがん関連タンパク質を標的とする有効性が市場需要を促進

患者の遺伝的・分子的プロファイルに基づいて治療法を調整する精密医療は、標的治療をもたらしました。慢性骨髄性白血病（CML）とフィラデルフィア染色体陽性急性リンパ芽球性白血病（Ph+ALL）の治療薬として開発されているダサチニブは、この技術の一例です。スプリセルは、チロシンキナーゼの活性を低下させることで、がん細胞の発生を促すシグナル伝達経路を遮断し、標準的な化学療法に代わる、より効果的で毒性の低い治療法を提供します。

スプリセル市場-主な洞察

弊社のリサーチアナリストの分析によると、世界のスプリセル市場は予測期間（2023-2030年）に約5.2%のCAGRで毎年成長すると予測されています。

スプリセル産業は、チロシンキナーゼとして知られる特定のがん関連タンパク質を標的とするその有効性により、著しい速度で成長すると予測されています。

デモグラフィックセグメンテーションに基づくと、2022年には年齢別市場シェアが最大になります。

地域別では、アジア太平洋地域が2022年の収益でリードしています。

スプリセル市場- セグメンテーション分析：

世界のスプリセル市場は、デモグラフィック、サイコグラフィック、行動、地域に基づいてセグメント化されます。

市場はデモグラフィックに基づいて4つのカテゴリーに分けられる：年齢、性別、所得。年齢セグメントが市場を独占しています。スプリセル（ダサチニブ）の需要は、高齢者に多く見られる特定のタイプの白血病の治療に使用されることが大きな要因となっています。慢性骨髄性白血病（CML）およびフィラデルフィア染色体陽性急性リンパ芽球性白血病（Ph+ALL）は、高齢者層でますます頻度が高くなっており、スプリセルのような標的治療薬へのニーズが高まっています。

同市場はサイコグラフィックに基づき2つのカテゴリーに分けられる：生活習慣、態度。生活習慣分野は市場を独占しており、予測期間中もその優位性を維持するとみられます。スプリセル（ダサチニブ）の生活習慣の需要は、一般的に、治療に合わせて生活習慣を修正することで成り立っています。

スプリセル市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。アジア太平洋地域におけるスプリセル（ダサチニブ）の需要は、さまざまな変数によって継続的に成長しています。人口の拡大と高齢化により、この地域では慢性骨髄性白血病（CML）やフィラデルフィア染色体陽性急性リンパ芽球性白血病（Ph+ALL）などの血液悪性腫瘍の頻度が増加しています。第二に、ヘルスケアのインフラや診断法の進歩、革新的な治療薬の登場により、洗練された治療法に対する認識と需要が高まっています。第三に、アジア太平洋地域の製薬セクターと調査パートナーシップの拡大により、スプリセルのような標的薬がより身近なものとなっています。これらの要因は、同地域のスプリセルに対する旺盛な需要の一因となっており、生命を脅かす病気と闘う患者たちに希望を与えています。

目次

第1章 スプリセル市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 スプリセルの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 スプリセル産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 スプリセル市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 スプリセル市場情勢

  • スプリセル市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 スプリセル市場：デモグラフィック別

  • 概要
    • デモグラフィック別のセグメントシェア分析
    • 年齢
    • 性別
    • 所得

第8章 スプリセル市場：サイコグラフィック別

  • 概要
    • サイコグラフィック別のセグメントシェア分析
    • 生活習慣
    • 態度

第9章 スプリセル市場：行動別

  • 概要
    • 行動別のセグメントシェア分析
    • 使用率
    • コンプライアンス
    • 治療歴

第10章 スプリセル市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：スプリセル業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Bristol-Myers Squibb（BMS）
    • Novartis
    • Teva Pharmaceutical Industries
    • Mylan
    • Accord Healthcare
    • Sun Pharma
    • Dr Reddy's Laboratories
    • Aurobindo Pharma
    • LUCIUS Pharma

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Psychographics
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sprycel Market: Demographic Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Demographic
  • TABLE Global Sprycel Market, by Demographic 2018-2030 (USD Million)
  • TABLE Sprycel Market: Psychographic Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Psychographic
  • TABLE Global Sprycel Market, by Psychographic 2018-2030 (USD Million)
  • TABLE Sprycel Market: Behavioral Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Behavioral
  • TABLE Global Sprycel Market, by Behavioral 2018-2030 (USD Million)
  • TABLE Sprycel Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sprycel Market, by Region 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE North America Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Europe Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Latin America Sprycel Market, by Behavioral, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Demographic, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Psychographic, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sprycel Market, by Behavioral, 2018-2030 (USD Million)
目次
Product Code: ANV1968

REPORT HIGHLIGHT

Sprycel Market size was valued at USD 5,470 Million in 2022, expanding at a CAGR of 5.2% from 2023 to 2030.

Sprycel (dasatinib) is a prescription drug used to treat some kinds of leukemia as well as other blood diseases. It belongs to the tyrosine kinase inhibitor family of medicines. Sprycel works by inhibiting the function of particular proteins involved in cancer cell proliferation and spread. This drug is used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). It is normally administered orally and plays an important role in treating certain hematologic malignancies, improving patient outcomes, and slowing disease progression.

Sprycel Market- Market Dynamics

Its efficacy in targeting specific cancer-related proteins, known as tyrosine kinases propel market demand

Precision medicine, which tailor's therapies based on a patient's genetic and molecular profile, has resulted in targeted therapy. Dasatinib, which is being developed as a therapy for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), is an example of this technique. Sprycel interrupts the signaling pathways that drive cancer cell development by reducing the activity of tyrosine kinases, providing a more effective and less toxic alternative to standard chemotherapy and thereby improving the prognosis for patients with these illnesses.

Sprycel Market- Key Insights

As per the analysis shared by our research analyst, the global Sprycel market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2023-2030)

The Sprycel industry is projected to grow at a significant rate due to Its efficacy in targeting specific cancer-related proteins, known as tyrosine kinases.

Based on Demographic segmentation, Age was predicted to show maximum market share in the year 2022

Based on Psychographic segmentation, Lifestyle was the leading Demographic in 2022

On the basis of region, Asia Pacific was the leading revenue generator in 2022

Sprycel Market- Segmentation Analysis:

The Global Sprycel Market is segmented on the basis of Demographic, Psychographic, Behavioral, and Region.

The market is divided into four categories based on Demographic: Age, Gender, Income. The Age segment dominates the market. Sprycel (dasatinib) demand is largely driven by its usage in treating particular types of leukaemia that are more common in older persons. Chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) are becoming increasingly frequent in the elderly population, increasing need for targeted medicines such as Sprycel.

The market is divided into two categories based on Psychographic: Lifestyle, Attitudes. The Lifestyle sector dominates the market and is likely to maintain its dominance during the forecast period. Sprycel (dasatinib) lifestyle demand generally consists of people modifying their habits to accommodate therapy. To manage possible side effects, patients may need to stick to a regular prescription regimen and adopt dietary and exercise changes. While receiving Sprycel medication, lifestyle decisions that promote general well-being are often prioritized.

Sprycel Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Sprycel (dasatinib) demand in the Asia-Pacific area has been continuously growing due to a variety of variables. Owing to population expansion and aging, the area has seen an increase in the frequency of hematological malignancies such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Second, advances in healthcare infrastructure, diagnostics, and the availability of innovative therapeutics have increased awareness of and demand for sophisticated treatments. Third, the Asia-Pacific region's expanding pharmaceutical sector and research partnerships are making targeted medicines like Sprycel more accessible. These factors contribute to the region's strong demand for Sprycel, giving patients fighting these life-threatening illnesses hope.

Sprycel Market- Competitive Landscape:

Several main companies dominate the competitive landscape of tyrosine kinase inhibitors for hematological malignancies, including Sprycel (dasatinib). Sprycel's maker, Bristol Myers Squibb, has a substantial market share. However, competition comes from other pharmaceutical firms that manufacture comparable medications, such as imatinib and nilotinib. Competition is aided by ongoing research efforts to create more effective and focused medicines in this class. Furthermore, generic versions of these drugs have an impact on the landscape by offering patients with more cost choices. The competitive environment encourages innovation and guarantees that patients with leukaemia and associated illnesses have access to a variety of treatment alternatives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SPRYCEL MARKET KEY PLAYERS

  • Bristol-Myers Squibb (BMS)
  • Novartis
  • Teva Pharmaceutical Industries
  • Mylan
  • Accord Healthcare
  • Sun Pharma
  • Dr Reddy's Laboratories
  • Aurobindo Pharma
  • LUCIUS Pharma

GLOBAL SPRYCEL MARKET, BY DEMOGRAPHIC

  • Age
  • Gender
  • Income

GLOBAL SPRYCEL MARKET, BY PSYCHOGRAPHIC

  • Lifestyle
  • Attitudes

GLOBAL SPRYCEL MARKET, BY BEHAVIORAL

  • Usage Rate
  • Compliance
  • Treatment History

GLOBAL SPRYCEL MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sprycel Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sprycel Market Snippet by Demographic
    • 2.1.2. Sprycel Market Snippet by Psychographic
    • 2.1.3. Sprycel Market Snippet by Behavioral
    • 2.1.4. Sprycel Market Snippet by Country
    • 2.1.5. Sprycel Market Snippet by Region
  • 2.2. Competitive Insights

3. Sprycel Key Market Trends

  • 3.1. Sprycel Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sprycel Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sprycel Market Opportunities
  • 3.4. Sprycel Market Future Trends

4. Sprycel Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sprycel Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sprycel Market Landscape

  • 6.1. Sprycel Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sprycel Market - By Demographic

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Demographic, 2022 & 2030 (%)
    • 7.1.2. Age
    • 7.1.3. Gender
    • 7.1.4. Income

8. Sprycel Market - By Psychographic

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Psychographic, 2022 & 2030 (%)
    • 8.1.2. Lifestyle
    • 8.1.3. Attitudes

9. Sprycel Market - By Behavioral

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Behavioral, 2022 & 2030 (%)
    • 9.1.2. Usage Rate
    • 9.1.3. Compliance
    • 9.1.4. Treatment History

10. Sprycel Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Sprycel Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Sprycel Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Sprycel Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Sprycel Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Sprycel Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Demographic, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Psychographic, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Behavioral, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Sprycel Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Bristol-Myers Squibb (BMS)
    • 11.2.2. Novartis
    • 11.2.3. Teva Pharmaceutical Industries
    • 11.2.4. Mylan
    • 11.2.5. Accord Healthcare
    • 11.2.6. Sun Pharma
    • 11.2.7. Dr Reddy's Laboratories
    • 11.2.8. Aurobindo Pharma
    • 11.2.9. LUCIUS Pharma

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us